The impact of epilepsy from the patient's perspective II: views about therapy and health care

A national survey of 1023 people with epilepsy in the US assessed their att itudes about their therapies. Subjects were drawn from responders to a prev ious national survey of US households or from those who phoned the Epilepsy Foundation. Overall response rate was 49%. Approximately 90% of the respon dents were taking medications for their epilepsy. Only 56% were on monother apy, while 26% were taking two, 6% three, and 2% four medications. Only 68% of respondents were very satisfied with their current seizure medications. When asked to rank five areas of importance regarding their seizure medica tion, the rank order (highest to lowest) was seizure control, fewer side ef fects, convenient dosing regimens and cost. Adverse medication events were listed in descending rank order as problems with cognition, energy level, s chool performance, childbearing, coordination, and sexual function. Inter-i ndividual differences in side effects of concern were listed, suggesting me dication choices should be individualized according to potential side effec ts. Twenty percent of 920 respondents adjusted their medications on their o wn, by adjusting amount (62%), dosing schedule (31%), or both (3%). Eighty percent of respondents were satisfied with their medical care systems. In t his group, 82% had health insurance that covered epilepsy. The large majori ty (94%) of respondents had seen a neurologist. Subjects expressed dissatis faction about time limits and lack of accessible information about epilepsy . people with epilepsy are generally satisfied with efforts to treat their disorder, but adverse events are of concern. Many patients requested more i nformation about epilepsy. (C) 2000 Elsevier Science B.V. All rights reserv ed.